| 1 |
32592909 | ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias. | 2020 Aug |
1 |
| 2 |
31762943 | Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia. | 2019 Nov 12 |
1 |
| 3 |
28061447 | The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia. | 2017 Feb 21 |
3 |
| 4 |
26139428 | Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. | 2016 Mar |
2 |
| 5 |
26292723 | Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia. | 2015 Aug 21 |
3 |
| 6 |
26630553 | Discovery of (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-(dimethylamino)ethanone (CHMFL-FLT3-122) as a Potent and Orally Available FLT3 Kinase Inhibitor for FLT3-ITD Positive Acute Myeloid Leukemia. | 2015 Dec 24 |
3 |